Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Double-Blind, Multicenter, Extension Study to Evaluate the Safety and Efficacy of DAC HYP in Subjects With Multiple Sclerosis Who Have Completed Treatment in Study 205MS201 (SELECT)

NCT00870740 is registered in ClinicalTrials.gov with Biogen as lead sponsor.

NCT NCT00870740
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00870740 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Double-Blind, Multicenter, Extension Study to Evaluate the Safety and Efficacy of DAC HYP in Subjects With Multiple Sclerosis Who Have Completed Treatment in Study 205MS201 (SELECT)
Lead sponsor
Biogen
Phase
Phase 2
Overall status
Completed
Start date
February 28, 2009
Completion date
October 31, 2012
Enrollment
517 (actual)
Sites
58

Conditions

As the registry lists them; a condition with its own page is linked.

relapsing-remitting multiple sclerosis